Vasundhara Rasayans Stock Screener | Share Price & Fundamental Analysis
VRL
Pharmaceuticals
Screen Vasundhara Rasayans share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price BSE
₹156.60
▼
-4.40 (-2.73%)
Market Cap
₹51.20 Cr.
P/E Ratio (TTM)
11.30
P/B Ratio
1.31
EPS (TTM)
₹13.36
Dividend Yield
1.24%
Debt to Equity
0.09
52W High
₹306.30
52W Low
₹156.60
Operating Margin
12.00%
Profit Margin
13.89%
Revenue (TTM)
₹36.00
EBITDA
₹7.00
Net Income
₹5.00
Total Assets
₹43.00
Total Equity
₹36.00
Vasundhara Rasayans Share Price History - Stock Screener Chart
Screen VRL historical share price movements with interactive charts. Analyze price trends and patterns.
Vasundhara Rasayans Company Profile - Fundamental Screener
Screen Vasundhara Rasayans company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for VRL shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE406F01010
Vasundhara Rasayans Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen VRL balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 43 | 37 | 35 | 26 | 23 | 25 | 21 | 20 | 14 | 15 |
| Current Assets | 40 | 35 | 34 | 24 | 13 | 24 | 21 | 20 | 7 | 8 |
| Fixed Assets | 3 | 2 | 1 | 1 | 1 | 0 | 0 | 0 | 7 | 7 |
| Liabilities | ||||||||||
| Total Liabilities | 43 | 37 | 35 | 26 | 23 | 25 | 21 | 20 | 14 | 15 |
| Current Liabilities | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 1 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 36 | 32 | 27 | 22 | 20 | 17 | 15 | 14 | 7 | 7 |
| Share Capital | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Reserves & Surplus | 32 | 29 | 24 | 18 | 17 | 14 | 12 | 11 | 4 | 4 |
Screen VRL income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 36 | 36 | 39 | 40 | 28 | 24 | 22 | 21 | 25 | 16 | 16 | 19 |
| Expenses | 29 | 30 | 31 | 32 | 25 | 20 | 19 | 19 | 15 | 14 | 14 | 17 |
| EBITDA | 7 | 6 | 8 | 8 | 3 | 4 | 4 | 2 | 10 | 2 | 2 | 2 |
| Operating Profit % | 12.00% | 12.00% | 17.00% | 15.00% | 8.00% | 14.00% | 13.00% | 6.00% | 11.00% | 11.00% | 8.00% | 8.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| Profit Before Tax | 6 | 6 | 8 | 8 | 3 | 4 | 4 | 2 | 9 | 1 | 0 | 1 |
| Tax | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 3 | 1 | 0 | 0 |
| Net Profit | 5 | 4 | 6 | 6 | 2 | 3 | 3 | 2 | 7 | 1 | 0 | 1 |
| EPS | 14.30 | 13.36 | 18.44 | 17.59 | 6.84 | 9.24 | 9.40 | 4.57 | 20.51 | 1.45 | 0.74 | 1.84 |
Vasundhara Rasayans Cash Flow Screener - Liquidity Fundamentals
Screen VRL cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -6 | 6 | -7 | 8 | 0 | 0 | 0 | -11 | 2 | 1 |
| Investing Activities | 1 | -1 | 1 | 1 | 0 | 1 | 1 | 13 | 0 | 0 |
| Financing Activities | 1 | -3 | 2 | 1 | -1 | -1 | -1 | -2 | -2 | -1 |
| Net Cash Flow | -4 | 2 | -3 | 10 | 0 | 1 | 0 | 0 | 0 | 0 |
Screen VRL shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 61.98% | 61.98% | 61.98% | 61.98% | 61.98% | 61.98% | 61.98% | 61.98% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 30.19% | 30.04% | 30.05% | 30.26% | 29.86% | 30.38% | 30.34% | 30.52% |
| Other Holding | 7.82% | 7.97% | 7.97% | 7.76% | 8.16% | 7.64% | 7.68% | 7.49% |
| Shareholder Count | 6,237 | 6,328 | 6,323 | 6,330 | 6,175 | 5,627 | 5,395 | 5,510 |
Vasundhara Rasayans Dividend Screener - Share Yield Analysis
Screen VRL dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹2.00 | 1.24% |
| 2024-March | ₹2.00 | 0.87% |
| 2023-March | ₹2.00 | 1.04% |
| 2022-March | ₹1.00 | 0.80% |
| 2021-March | ₹1.50 | 1.30% |
| 2020-March | ₹1.50 | 2.15% |
| 2019-March | ₹1.00 | 4.51% |
| 2018-March | ₹1.00 | 2.70% |
| 2017-March | ₹1.00 | 1.94% |
Vasundhara Rasayans Index Membership - Market Screener Classification
Screen VRL by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Vasundhara Rasayans Market Events Screener - Corporate Actions
Screen VRL market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Dividend | ₹ 2.00 /share | 5.28% | ||
| Dividend | ₹ 1.00 /share | -7.96% | ||
| Dividend | ₹ 1.50 /share | 41.55% | ||
| Dividend | ₹ 2.00 /share | -0.13% | ||
| Annual General Meeting | NA | -3.19% | ||
| Annual General Meeting | NA | 3.41% | ||
| 2025-11-13 | 2025-11-13 | Quarterly Result Announcement | NA | -3.58% |
| 2025-08-13 | 2025-08-13 | Quarterly Result Announcement | NA | -3.50% |
| 2025-05-28 | 2025-05-28 | Quarterly Result Announcement | NA | -3.21% |
| 2025-02-10 | 2025-02-10 | Quarterly Result Announcement | NA | -4.93% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -3.00% |
| 2023-08-22 | 2023-08-23 | Dividend | ₹ 2.00 /share | 43.94% |
Vasundhara Rasayans Competitors Screener - Peer Comparison
Screen VRL competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 423,531 | 40.31 | 54,729 | 9.71% | 10,980 | 52.13 |
| Divis Laboratories | 175,209 | 70.47 | 9,712 | 18.67% | 2,191 | 59.83 |
| Torrent Pharmaceuticals | 135,920 | 63.66 | 11,539 | 6.99% | 1,911 | 70.17 |
| Cipla | 118,314 | 21.71 | 28,410 | 7.12% | 5,291 | 36.98 |
| Dr Reddys Laboratories | 100,740 | 17.57 | 33,741 | 16.73% | 5,725 | 29.23 |
| Lupin | 100,085 | 23.02 | 22,910 | 13.74% | 3,306 | 65.89 |
| Mankind Pharma | 92,881 | 52.52 | 12,744 | 20.90% | 2,007 | 56.26 |
| Zydus Life Science | 91,260 | 18.16 | 23,511 | 18.55% | 4,615 | 41.07 |
| Aurobindo Pharma | 70,045 | 20.49 | 32,346 | 9.43% | 3,484 | 51.02 |
| Alkem Laboratories | 69,055 | 28.76 | 13,458 | 3.70% | 2,216 | 62.82 |
Vasundhara Rasayans Company Announcements - News Screener
Screen VRL latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2025-12-31 | Intimation Regarding Termination Of Lease And License Agreement . | View |
| 2025-12-31 | Closure of Trading Window | View |
| 2025-11-14 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-13 | FINANCIAL RESULTS FOR THE QUARTER AND HALF YEAR ENDED ON 13.11.2025 | View |
| 2025-11-13 | Board Meeting Outcome for OUTCOME OF THE BOARD MEETING HELD ON 13.11.2025 | View |
| 2025-11-05 | Board Meeting Intimation for Board Meeting Intimation To Consider And Approve The Un-Audited Financial Results For The Second Quarter Ended 31Stdecember 2023. | View |
| 2025-10-18 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-09-29 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-09-29 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-09-27 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-09-06 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-09-04 | Fixed Record Date For E-Voting In Connection With AGM | View |
| 2025-09-04 | Reg. 34 (1) Annual Report. | View |
| 2025-09-04 | Notice Of 38Th Annual General Meeting Scheduled To Be Held On Friday 26Th September 2025 | View |
| 2025-09-04 | Board Meeting Outcome for Outcome Of The Board Meeting Held On 04.09.2025 | View |
| 2025-09-01 | Board Meeting Intimation for Recommendation Of Dividend And AGM | View |
| 2025-08-14 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-08-13 | Unaudited Standalone And Consolidated Financial Results For Quarter Ended 3Oth June 2025 | View |
| 2025-08-13 | Board Meeting Outcome for Board Meeting Outcome For The Board Meeting Held On 13.08.2025. | View |
| 2025-08-04 | Board Meeting Intimation for Board Meeting Intimation To Consider And Approve The Un Audited Financial Results For The First Quartter Ended As On 30Th June2025 | View |